The effects of intraperitoneal chemotherapeutic agents on adhesion formation

Akgol G., Yildiz C., Karakus S., Koc M., Dogan M., Turan M., ...Daha Fazla

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, cilt.37, sa.6, ss.781-785, 2016 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 37 Sayı: 6
  • Basım Tarihi: 2016
  • Doi Numarası: 10.12892/ejgo3156.2016
  • Dergi Adı: EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.781-785
  • Anahtar Kelimeler: Intra-abdominal adhesions, Intraperitoneal chemotherapy, Cytoreductive surgery, PERITONEAL CARCINOMATOSIS, CYTOREDUCTIVE SURGERY, COLORECTAL-CANCER, PREVENTION, OBSTRUCTION, MANAGEMENT, RECURRENT
  • Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

Purpose: Intra-abdominal adhesions are a major complication of healing. Furthermore these adhesions may cause morbidity and sometimes mortality for patients, and also are a financial burden to the health system. Materials and Methods: Cecum abrasion was performed in all rats and solutions containing saline to group 1, 5-fluorouracil to group 2, cisplatin to group 3, paclitaxel to the group 4, and mitomycin-C were administered into the abdomen of the groups, respectively. The intra-abdominal adhesions were scored after the macroscopic evaluation. Results: Among the chemotherapeutic drugs, paclitaxel significantly increases occurring of intra-abdominal adhesions in comparison with the control group and the other drugs according to the evaluation of scoring and statistical studies. Conclusion: It is suggested to use the drugs which have a proven anti-adhesion feature or barriers to the patients who are going to be applied intraperitoneal chemotherapy with paclitaxel.